Interferon Alpha as a Tool for Gene Discovery in Human Lupus

  • Niewold, Timothy B (PI)

Project: Research project

Project Details

Description

DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is a poorly understood autoimmune syndrome characterized by significant morbidity and mortality. Clinical trials in SLE have largely been unsuccessful, and improved understanding of disease heterogeneity and underlying pathogenic factors will be required for efficient intervention in the disease process. The pathogenesis of SLE is driven by a combination of genetic risk factors and environmental influences which lead to an irreversible break in immunologic self-tolerance. Recent genetic studies in SLE have identified numerous novel susceptibility loci, most of which have a modest overall effect on disease susceptibility (odds ratios 1.2-1.3). These studies have used a standard case-control design, studying very large cohorts at high cost. New approaches are needed, as the cohort size required to detect genes with odds ratios
StatusFinished
Effective start/end date8/1/114/30/16

Funding

  • National Institutes of Health: $339,863.00
  • National Institutes of Health: $350,595.00
  • National Institutes of Health: $413,266.00
  • National Institutes of Health: $351,000.00
  • National Institutes of Health: $38,600.00
  • National Institutes of Health: $351,000.00

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.